Efficacy and safety of veliparib plus carboplatin or carboplatin alone with neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) after ≥4 years of follow-up: BrighTNess, a randomized, Phase 3 trial
- Citation:
- Ann Oncol vol 32 (5) abstr S408
- Meeting Instance:
- ESMO 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Funding:
- AFT
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3775